AngioDynamics reported $-6.35M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 108K 1.65M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
ICU Medical USD -15.73M 12.34M Dec/2025
Inogen USD -5.96M 373K Sep/2024
J&J USD 5.24B 119M Mar/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Smiths GBP 130M 38M Jun/2026
Surmodics USD -5.32M 6.22M Jun/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Terumo JPY 26.37B 6.28B Mar/2026
Trinity Biotech USD -5.14M 11.82M Sep/2025